Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDistrib. Fin. Regulatory News (DFCH)

Share Price Information for Distrib. Fin. (DFCH)

Share Price is delayed by 15 minutes
Get Live Data
56.50    0.00 (0.00%)
Bid:
55.00
Ask:
58.00
Spread: 3.00 (5.455%)
Market Cap: £92.71m
DFCH Live PriceLast checked at - London Stock Exchange

Intraday Distrib. Fin. Share Chart

Trading Update

4 Jul 2024 07:00

RNS Number : 0669V
Distribution Finance Cap. Hldgs PLC
04 July 2024
 

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation (EU no. 596/2014) as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018 (as amended from time to time).

 

4 July 2024

 

Distribution Finance Capital Holdings plc

("DF Capital" or the "Company" together with its subsidiaries the "Group")

 

 

Trading update for six months ended 30 June 2024

 

Continued momentum with full year results now expected to be significantly ahead of market expectations

 

Distribution Finance Capital Holdings plc, a specialist bank providing working capital solutions to dealers and manufacturers across the UK, is pleased to provide a trading update for the six months ended 30 June 2024.

· The Group has continued to see strong momentum during the period with new loan origination exceeding a record £709m, up c17% on the prior year (H1 2023: £607m).

· The Group's loan book at 30 June 2024 reached £600m, up c16% on the prior year (H1 2023: £519m) and which is in line with seasonal expectations. Whilst new loan origination remains strong, the Group has seen a normalisation of the seasonality in loan repayments during the year (i.e. an acceleration of dealer sales during the period March to September), a first since the onset of the global pandemic. 

· The Group now supports 90 manufacturer partners and its dealer customers total 1,250 on a net basis (H1 2023: 1,152) having added 165 new dealers in the period. Credit lines reached a record c£1.1bn, up c21% on prior year (30 June 2023: £926m).

· Average stock days, which measures the average age of loans outstanding, remains well within sector tolerances, extending marginally on a portfolio basis to 149 days (31 December 2023: 148 days) at the period end.

· In spite of the challenges of the macro-economic and higher interest rate environment, the Group's overdue accounts have continued to perform well and ahead of expectations through the period. 20 dealers (H1 2023: 29), including 10 cases in legal recovery, had arrears one day past due, representing c1.6% (H1 2023: c 2.5%) of the Group's dealer base. The Group's total arrears balance represented c0.5% (H1 2023: 2.5%) of its entire loan book.

In light of the strong performance during the six month period, the Group's underlying trading performance is expected to be ahead of market expectations for the full year, driven by stronger net interest income, lower impairments and loss provisions and stronger cost control.

Additionally, having prudently written off approximately £10m in respect of the RoyaleLife balance, the Group has continued in its pursuit of the fullest possible level of financial recovery. The Group is pleased to announce, having now exhausted all opportunities, that it has now recovered assets and cash and agreed legal settlement with related parties to the aggregate sum of c£4.7m, of which c£1.7m is expected to be recognised in H1 2024. The remaining £3m of this settlement amount is subject to the sale of assets (including property) by a third party and it is therefore anticipated that this will be recovered in the financial year ending 31 December 2025.

Given the Company's strong underlying operational and financial momentum and the financial recovery in relation to RoyaleLife, the Group expects to report a pre-tax profit for the six month ended 30 June 2024 of no less than £9.0m, which is significantly ahead of its expectations and more than the entire FY23 outturn of £4.6m. Accordingly, the Group expects its full year outturn for 2024 to significantly exceed market expectations.

The Group has also continued with the organic build of a hire purchase lending capability, which unlocks entry into significantly larger addressable markets than the Company's current offering, supporting the sales of its existing dealers and manufacturers to end-user consumers. The Group does not expect to start lending in this market adjacency until 2025, which is subject to regulatory approval.

The Company expects to provide a fuller update when it announces its interim results for the six months ended 30 June 2024 in September 2024.

 

Carl D'Ammassa, Chief Executive, commented: "2024 has started exceptionally well, with strong operational and commercial execution as well as portfolio management and control. Our products and services clearly resonate with our customers and seeing continued record new loan origination is a testament to the entire team's focus on providing high quality service and the deep relationships we have with our dealer and manufacturer partners. I am pleased with the Group's trading performance so far this year and this gives us confidence for the rest of the year. It is pleasing to see our efforts in working through the RoyaleLife situation deliver significant recoveries and upside potential to our financial expectations."

 

The person responsible for arranging the release of this announcement on behalf of the Company is Karen D'Souza (Company Secretary).

 

For further information contact:

Distribution Finance Capital Holdings plc

Carl D'Ammassa - Chief Executive Officer

+44 (0) 161 413 3391

Kam Bansil - Head of Investor Relations

+44 (0) 7779 229508

http://www.dfcapital-investors.com

 

Panmure Liberum Limited (Nomad and Broker)

+44 (0) 203 100 2000

Chris Clarke

William King

Anake Singh

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFIIDLIVIIS
Date   Source Headline
21st Apr 20217:00 amRNSFinal Results
30th Mar 202111:35 amRNSNotice of Results
18th Mar 20217:27 amRNSProgressive publishes new research
9th Mar 20215:37 pmRNSHolding(s) in Company
2nd Mar 202112:46 pmRNSHolding(s) in Company
25th Feb 202110:42 amRNSDirector/PDMR Shareholding
23rd Feb 20214:03 pmRNSHolding(s) in Company
23rd Feb 20211:07 pmRNSHolding(s) in Company
23rd Feb 20218:15 amRNSDirector/PDMR Shareholding
22nd Feb 202111:08 amRNSResult of General Meeting
5th Feb 20217:00 amRNSPlacing to raise £40 million
25th Jan 20217:00 amRNSFull Year Trading Update
9th Dec 20207:00 amRNSTrufin Loan Early Repayment
16th Nov 20207:00 amRNSDirector/PDMR Shareholding
6th Nov 202012:33 pmRNSDirector/PDMR Shareholding
5th Nov 20209:40 amRNSWholesale Funding Update
26th Oct 20207:00 amRNSDeposit raising reaches £50m milestone
21st Oct 20207:00 amRNSRepayment of TruFin plc Loan
14th Oct 20207:00 amRNSLaunch of Personal Savings Products
12th Oct 20207:00 amRNSStatement regarding Arrowgrass Master Fund Limited
7th Oct 20202:45 pmRNSSubsidiary Name Change
5th Oct 20207:00 amRNSWholesale Facility Update
2nd Oct 20202:22 pmRNSDirector/PDMR Shareholding
30th Sep 20206:10 pmRNSAGM Results
30th Sep 20207:00 amRNSInterim Results for the six months to June 2020
29th Sep 202010:55 amRNSDF Capital granted banking licence
16th Sep 20207:00 amRNSAppointment of Investec as Nomad and Broker
8th Sep 202011:17 amRNSGM Statement
4th Sep 20209:00 amRNSNotice of AGM
1st Sep 202011:46 amRNSSignificant Shareholder & PDMR Shareholding
25th Aug 20203:01 pmRNSWholesale Funding Update
21st Aug 20204:35 pmRNSPublication of Circular
21st Aug 20207:00 amRNSShare Capital Reorganisation and PDMR Notification
14th Aug 202011:55 amRNSAGM, Interim Results Timing, Rescheduling of loan
7th Aug 20207:00 amRNSBanking Licence & Business Trading Update
27th Jul 20203:07 pmRNSDirector/PDMR Shareholding
9th Jul 20207:00 amRNSDirector/PDMR Shareholding
6th Jul 20203:49 pmRNSDirector/PDMR Shareholding
2nd Jul 202010:54 amRNSChanges to interests of a significant shareholder
30th Jun 20207:00 amRNSDirector/PDMR Shareholding
26th Jun 20203:25 pmRNSAGM Postponement Statement
26th Jun 20207:00 amRNSFinal Results & Change of Registered Address
25th Jun 20207:00 amRNSTemporary Waiver & Timing of Annual Report
5th Jun 20207:00 amRNSAGM and timing of final results 2019
13th May 20207:00 amRNSBoard Update and Directorate Changes
11th May 20207:00 amRNSTemporary waiver granted by Lenders
28th Apr 20207:00 amRNSTrading Update April 2020
2nd Apr 20207:00 amRNSWaiver Extension and Bank Licence Update
5th Mar 20204:09 pmRNSStatement re CEO Commencement Date
5th Feb 20207:01 amRNSChief Exec appointment and Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.